The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Open accessAbstract
The spontaneous deamination of cytosine is a major source of transitions from C•G to T•A base pairs, which account for half of known pathogenic point mutations in humans. The ability to efficiently convert targeted A•T base pairs to G•C could therefore advance the study and treatment of genetic diseases. The deamination of adenine yields inosine, which is treated as guanine by polymerases, but no enzymes are known to deaminate adenine in DNA. Here we describe adenine base editors (ABEs) that mediate the conversion of A•T to G•C in genomic DNA. We evolved a transfer RNA adenosine deaminase to operate on DNA when fused to a catalytically impaired CRISPR-Cas9 mutant. Extensive directed evolution and protein engineering resulted in seventh-generation ABEs that convert targeted A•T base pairs efficiently to G•C (approximately 50% efficiency in human cells) with high product purity (typically at least 99.9%) and low rates of indels (typically no more than 0.1%). ABEs introduce point mutations more efficiently and cleanly, and with less off-target genome modification, than a current Cas9 nuclease-based method, and can install disease-correcting or disease-suppressing mutations in human cells. Together with previous base editors, ABEs enable the direct, programmable introduction of all four transition mutations without double-stranded DNA cleavage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using a seventh-generation evolved transfer RNA adenosine deaminase attached to dCas9, researchers demonstrated conversion of A*T base pairs to G*C base pairs in a targeted fashion at efficiencies of around 50% with few undesired mutations in human cells.”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Gaudelli et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenine base editor (ABE), first described in 2017, generally does not induce DSBs (<1%) and is therefore a favorable alternative to Cas9 for single and multiplex gene knockouts.12,14”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Yet, these mutations occur significantly more often in human disease than transversion mutations (62% transition vs 38% transversion29,63).”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CBE converts cytosine to thymine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“ABE catalyzes the editing from adenine to guanine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“Base editors are one such tool, which couple Cas9 nickases with nucleotide deaminases to achieve single nucleotide conversion without introducing DSBs.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“Next-generation CRISPR tools, such as base editors, use enzymes like cytidine or adenine deaminases fused to Cas9 to introduce single nucleotide variants (SNVs) without DSBs.12,13”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Fusing adenine deaminase (an evolved TadA heterodimer) to a nickase-Cas9 creates an adenine base editor (ABE) that mediates A > G base changes via an inosine intermediate29”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [29]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [49]
Experimental — accuracy not yet measuredIn the citing paper
“Consistent with the literature1, ABE6.3 resulted in the highest A>G base editing efficiency at position A9 (6.9 ± 2.0%,2 µg ABE6.3) (Supplementary Fig. 1) and editing efficiency was dependent of the ABE enzyme concentration.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“Adenine BEs comprise an evolved Escherichia coli TadA (ecTadA*, a tRNA adenosine deaminase evolved to accept DNA substrate) and Cas9 nickase, and mediate A•T to G•C substitutions1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“The ABE editing window occupies positions ~4–9 with the 1st, 5’ nucleotide (nt) of the candidate sgRNA counted as position 1 1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“Point mutations are a frequent cause of genetic disease, with ~50% of disease point mutations being G:C>A:T 1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Self-citationClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., et al. (2016) · Science · doi:10.1126/science.aaf8729 · Cited by 1,349
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M. (2016) · Nature · doi:10.1038/nature17664 · Cited by 951
Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion
Zong, Y., Wang, Y., Li, C., Zhang, R., Chen, K., Ran, Y., Qiu, J., Wang, D., & Gao, C. (2017) · Nature Biotechnology · doi:10.1038/nbt.3811 · Cited by 896
Komor, A. C., Zhao, K. T., Packer, M. S., Gaudelli, N. M., Waterbury, A. L., Koblan, L. W., Kim, Y. B., Badran, A. H., & Liu, D. R. (2017) · Science Advances · doi:10.1126/sciadv.aao4774 · Cited by 783
Self-citationKim, Y. B., Komor, A. C., Levy, J. M., Packer, M. S., Zhao, K. T., & Liu, D. R. (2017) · Nature Biotechnology · doi:10.1038/nbt.3803 · Cited by 758
Self-citationA system for the continuous directed evolution of biomolecules
Esvelt, K. M., Carlson, J. C., & Liu, D. R. (2011) · Nature · doi:10.1038/nature09929 · Cited by 694
Self-citationUracil in DNA – occurrence, consequences and repair
Krokan, H. E., Drabløs, F., & Slupphaug, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205996 · Cited by 500
Cited by
Sorted by citations
Items 401–500 of 1,024
CRISPR-Based Genome Editing Tools: Insights into Technological Breakthroughs and Future Challenges
Mushtaq, M., Dar, A. A., Skalický, M., Tyagi, A., Bhagat, N., Basu, U., Bhat, B. A., Zaid, A., Ali, S., Dar, T. U. H., et al. (2021) · Genes · doi:10.3390/genes12060797 · Cited by 100
Nuclear and mitochondrial DNA editing in human cells with zinc finger deaminases
Lim, K., Cho, S.-I., & Kim, J. (2022) · Nature Communications · doi:10.1038/s41467-022-27962-0 · Cited by 100
Opportunities and Challenges for Molecular Understanding of Ciliopathies–The 100,000 Genomes Project
Wheway, G., Genomics England Research Consortium, & Mitchison, H. M. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00127 · Cited by 99
Highly efficient and precise base editing by engineered dCas9-guide tRNA adenosine deaminase in rats
Ma, Y., Yu, L., Zhang, X., Xin, C., Huang, S., Bai, L., Chen, W., Gao, R., Li, J., Pan, S., et al. (2018) · Cell Discovery · doi:10.1038/s41421-018-0047-9 · Cited by 103
Pazi, K., Chathoth, K. T., Taylor, G. C. A., Meynert, A. M., Ballinger, T. J., Kelder, M. J. E., Lalevée, S., Sanli, I., Feil, R., & Wood, A. J. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2005595 · Cited by 99
Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease
Ernst, M. P. T., Broeders, M., Herrero-Hernandez, P., Oussoren, E., van der Ploeg, A. T., & Pijnappel, W. W. M. P. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.06.022 · Cited by 103
Functional Genomics via CRISPR–Cas
Ford, K. M., McDonald, D., & Mali, P. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.034 · Cited by 103
Phenotypic and genome-wide association with the local environment of Arabidopsis
Ferrero‐Serrano, Á., & Assmann, S. M. (2019) · Nature Ecology & Evolution · doi:10.1038/s41559-018-0754-5 · Cited by 99
Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing
Maule, G., Arosio, D., & Cereseto, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113903 · Cited by 102
Nadakuduti, S. S., & Enciso-Rodríguez, F. E. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2020.637159 · Cited by 99
CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
Cheng, H., Zhang, F., & Ding, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101649 · Cited by 100
Modelling metabolic diseases and drug response using stem cells and organoids
Hu, W., & Lazar, M. A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00733-z · Cited by 99
Base-editing mutagenesis maps alleles to tune human T cell functions
Schmidt, R. L. J., Ward, C. C., Dajani, R., Armour-Garb, Z., Ota, M., Allain, V., Hernandez, R., Layeghi, M., Xing, G., Goudy, L., et al. (2023) · Nature · doi:10.1038/s41586-023-06835-6 · Cited by 101
Kato-Inui, T., Takahashi, G., Hsu, S., & Miyaoka, Y. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky264 · Cited by 101
Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies
Magrin, E., Miccio, A., & Cavazzana, M. (2019) · Blood · doi:10.1182/blood.2019000949 · Cited by 100
Choi, E. H., Suh, S., Foik, A. T., Leinonen, H., Newby, G. A., Gao, X. D., Banskota, S., Hoang, T. V., Du, S. W., Dong, Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29490-3 · Cited by 97
Self-citationRozas, P., Kessi‐Pérez, E. I., & Martı́nez, C. (2022) · Biological Research · doi:10.1186/s40659-022-00399-x · Cited by 99
A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing
Sichani, A. S., Ranjbar, M., Baneshi, M., Zadeh, F. T., & Fallahi, J. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00639-1 · Cited by 105
RNA chemistry and therapeutics
Wang, S., Weissman, D., & Dong, Y. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01237-x · Cited by 109
Tadić, V., Josipović, G., Zoldoš, V., & Vojta, A. (2019) · Methods · doi:10.1016/j.ymeth.2019.05.003 · Cited by 99
Chen, Q., Zhang, Y., & Yin, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.014 · Cited by 99
Newsom, S. N., Parameshwaran, H. P., Martin, L., & Rajan, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.619763 · Cited by 99
Massively parallel phenotyping of coding variants in cancer with Perturb-seq
Ursu, O., Neal, J. T., Shea, E., Thakore, P. I., Jerby-Arnon, L., Nguyen, L., Dionne, D., Diaz, C., Bauman, J., Mosaad, M. M., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01160-7 · Cited by 96
Prime editing with genuine Cas9 nickases minimizes unwanted indels
Lee, J., Lim, K., Kim, A., Mok, Y. G., Chung, E., Cho, S.-I., Lee, J. M., & Kim, J. (2023) · Nature Communications · doi:10.1038/s41467-023-37507-8 · Cited by 103
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
Hussen, B. M., Rasul, M. F., Abdullah, S. R., Hidayat, H. J., Faraj, G. S. H., Ali, F. A., Salihi, A. B., Baniahmad, A., Ghafouri‐Fard, S., Rahman, M., et al. (2023) · Military Medical Research · doi:10.1186/s40779-023-00468-6 · Cited by 106
Cas9 exo-endonuclease eliminates chromosomal translocations during genome editing
Yin, J., Lu, R., Xin, C., Wang, Y., Ling, X., Li, D., Zhang, W., Liu, M., Xie, W., Kong, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28900-w · Cited by 104
Structural basis for RNA-guided DNA cleavage by IscB-ωRNA and mechanistic comparison with Cas9
Schuler, G. A., Hu, C., & Ke, A. (2022) · Science · doi:10.1126/science.abq7220 · Cited by 95
CRISPR/Cas9 Landscape: Current State and Future Perspectives
Tyumentsev, A. I., Tyumentsev, A. I., & Акимкин, В. Г. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216077 · Cited by 98
Optimizing CRISPR/Cas9 for the Diatom Phaeodactylum tricornutum
Stukenberg, D., Zauner, S., Dell’Aquila, G., & Maier, U. G. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.00740 · Cited by 100
CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification
Oakes, B. L., Fellmann, C., Rishi, H. S., Taylor, K. L., Ren, S. M., Nadler, D. C., Yokoo, R., Arkin, A. P., Doudna, J. A., & Savage, D. F. (2019) · Cell · doi:10.1016/j.cell.2018.11.052 · Cited by 94
Osborn, M. J., Newby, G. A., McElroy, A. N., Knipping, F., Nielsen, S. C., Riddle, M. J., Xia, L., Chen, W., Eide, C. R., Webber, B. R., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.07.701 · Cited by 100
Self-citationLi, C., Georgakopoulou, A., Mishra, A., Gil, S., Hawkins, R. D., Yannaki, E., & Lieber, A. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003702 · Cited by 96
Next-Generation CRISPR Technologies and Their Applications in Gene and Cell Therapy
C., M. A. Z., & Gaj, T. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.10.010 · Cited by 99
Wannier, T. M., Ciaccia, P. N., Ellington, A. D., Filsinger, G. T., Isaacs, F. J., Javanmardi, K., Jones, M. A., Kunjapur, A. M., Nyerges, Á., Pál, C., et al. (2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-020-00006-x · Cited by 101
Overcoming tumor resistance mechanisms in CAR-NK cell therapy
Valeri, A., García-Ortiz, A., Castellano, E., Córdoba, L., Maroto-Martín, E., Encinas, J., Leivas, A., Río, P., & Martínez‐López, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.953849 · Cited by 96
High-purity production and precise editing of DNA base editing ribonucleoproteins
Jang, H.-K., Jo, D. H., Lee, S.-N., Cho, C. S., Jeong, Y. K., Jung, Y., Yu, J., Kim, J. H., Woo, J.-S., & Bae, S. (2021) · Science Advances · doi:10.1126/sciadv.abg2661 · Cited by 93
Wang, Y., Wang, Z., Chen, Y., Hua, X., Yu, Y., & Ji, Q. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.09.003 · Cited by 94
The Promise and the Hope of Gene Therapy
Papanikolaou, E., & Bosio, A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.618346 · Cited by 101
Plant base editing and prime editing: The current status and future perspectives
Li, J., Zhang, C., He, Y., Li, S., Yan, L., Li, Y., Zhu, Z., & Xia, L. (2022) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13425 · Cited by 94
Base editing screens map mutations affecting interferon-γ signaling in cancer
Coelho, M. A., Cooper, S., Strauß, M. E., Karakoç, E., Bhosle, S. G., Gonçalves, E., Picco, G., Burgold, T., Cattaneo, C. M., Veninga, V., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2022.12.009 · Cited by 94
In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model
Carreras, A., Pane, L. S., Nitsch, R., Madeyski-Bengtson, K., Porritt, M. J., Akçakaya, P., Taheri‐Ghahfarokhi, A., Ericson, E., Bjursell, M., Pérez-Alcázar, M., et al. (2019) · BMC Biology · doi:10.1186/s12915-018-0624-2 · Cited by 93
Off-Target Editing by CRISPR-Guided DNA Base Editors
Park, S., & Beal, P. A. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00573 · Cited by 95
A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants
Kweon, J., Jang, A.-H., Shin, H. R., See, J.-E., Lee, W., Lee, J. W., Chang, S., Kim, K., & Kim, Y. (2019) · Oncogene · doi:10.1038/s41388-019-0968-2 · Cited by 93
Endogenous Type I CRISPR-Cas: From Foreign DNA Defense to Prokaryotic Engineering
Zheng, Y., Li, J., Wang, B., Han, J., Hao, Y., Wang, S., Ma, X., Yang, S., Ma, L., Li, Y., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00062 · Cited by 92
Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox
Koonin, E. V., Gootenberg, J. S., & Abudayyeh, O. O. (2023) · Biochemistry · doi:10.1021/acs.biochem.3c00159 · Cited by 95
Development of miniature base editors using engineered IscB nickase
Han, D., Xiao, Q., Wang, Y., Zhang, H., Dong, X., Li, G., Kong, X., Wang, S., Song, J., Zhang, W., et al. (2023) · Nature Methods · doi:10.1038/s41592-023-01898-9 · Cited by 92
Improvements in Gene Editing Technology Boost Its Applications in Livestock
Périssé, I. V., Fan, Z., Singina, G. N., White, K. L., & Polejaeva, I. A. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.614688 · Cited by 88
CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives
Chan, Y.-T., Lu, Y., Wu, J., Zhang, C., Tan, H., Bian, Z., Wang, N., & Feng, Y. (2022) · Theranostics · doi:10.7150/thno.71144 · Cited by 93
Design of highly functional genome editors by modeling the universe of CRISPR-Cas sequences
Ruffolo, J. A., Nayfach, S., Gallagher, J., Bhatnagar, A., Beazer, J., Hussain, R., Russ, J., Yip, J., Hill, E., Pacesa, M., et al. (2024) · doi:10.1101/2024.04.22.590591 · Cited by 90
CRISPR–Cas9 Gene Editing: Curing Genetic Diseases by Inherited Epigenetic Modifications
Kolanu, N. D. (2024) · Global Medical Genetics · doi:10.1055/s-0044-1785234 · Cited by 93
Fei, H., Li, Y., Liu, Y., Wei, J., Chen, A. A., & Gao, C. (2025) · Cell · doi:10.1016/j.cell.2025.06.014 · Cited by 96
Highly efficient base editing in bacteria using a Cas9-cytidine deaminase fusion
Zheng, K., Wang, Y., Li, N., Jiang, F., Wu, C.-X., Liu, F., Chen, H., & Liu, Z. (2018) · Communications Biology · doi:10.1038/s42003-018-0035-5 · Cited by 89
Simon, A. J., d’Oelsnitz, S., & Ellington, A. D. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0157-4 · Cited by 90
Vision rescue via unconstrained in vivo prime editing in degenerating neural retinas
Qin, H., Zhang, W., Zhang, S., Feng, Y., Xu, W., Jia, Q., Zhang, Q., Xu, C., Liu, S., Zhang, J., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20220776 · Cited by 95
Efficient Gene Silencing by Adenine Base Editor-Mediated Start Codon Mutation
Wang, X., Liu, Z., Li, G., Dang, L., Huang, S., He, L., Ma, Y., Li, C., Liu, M., Yang, G., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.11.022 · Cited by 89
Base Editing in Plants: Applications, Challenges, and Future Prospects
Azameti, M. K., & Dauda, W. P. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.664997 · Cited by 88
Engineering biosynthetic enzymes for industrial natural product synthesis
Galanie, S. S., Entwistle, D. A., & Lalonde, J. J. (2020) · Natural Product Reports · doi:10.1039/c9np00071b · Cited by 91
Genome editing in cereal crops: an overview
Matres, J. M., Hilscher, J., Datta, A., Armario-Nájera, V., Baysal, C., He, W., Huang, X., Zhu, C., کامران, ر. و., Trijatmiko, K. R., et al. (2021) · Transgenic Research · doi:10.1007/s11248-021-00259-6 · Cited by 90
Glycosylase-based base editors for efficient T-to-G and C-to-G editing in mammalian cells
Ye, L., Zhao, D., Li, J., Wang, Y., Li, B., Yang, Y., Hou, X., Wang, H., Wei, Z., Liu, X., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-02050-w · Cited by 91
Engineering TALE-linked deaminases to facilitate precision adenine base editing in mitochondrial DNA
Cho, S.-I., Lim, K., Hong, S., Lee, J., Kim, A., Lim, C. J., Ryou, S., Lee, J. M., Mok, Y. G., Chung, E., et al. (2024) · Cell · doi:10.1016/j.cell.2023.11.035 · Cited by 88
Intracellular Chemistry: Integrating Molecular Inorganic Catalysts with Living Systems
Ngo, A. H., Bose, S., & Do, L. H. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201800504 · Cited by 87
Dubrot, J., Lane-Reticker, S. K., Kessler, E., Ayer, A., Mishra, G., Wolfe, C. H., Zimmer, M. D., Du, P. P., Mahapatra, A., Ockerman, K. M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.001 · Cited by 87
Attaining the promise of plant gene editing at scale
Nasti, R. A., & Voytas, D. F. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004846117 · Cited by 90
Revolutionizing DNA repair research and cancer therapy with CRISPR–Cas screens
Awwad, S. W., Serrano-Benítez, A., Thomas, J. C., Gupta, V., & Jackson, S. P. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00571-x · Cited by 93
Efficient high-precision homology-directed repair-dependent genome editing by HDRobust
Riesenberg, S., Kanis, P., Macak, D., Wollny, D., Düsterhöft, D., Kowalewski, J., Helmbrecht, N., Maričić, T., & Pääbo, S. (2023) · Nature Methods · doi:10.1038/s41592-023-01949-1 · Cited by 87
Krishnan, A., Iyer, L. M., Holland, S. J., Boehm, T. L. J., & Aravind, L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720897115 · Cited by 87
Development and Application of Base Editors
Yang, B., Yang, L. C., & Chen, J. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.0001 · Cited by 87
CRISPR-mediated accelerated domestication of African rice landraces
Lacchini, E., Kiegle, E., Castellani, M., Adam, H., Jouannic, S., Gregis, V., & Kater, M. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229782 · Cited by 86
Álvarez, B., Mencía, M., de Lorenzo, V., & Fernández, L. Á. (2020) · Nature Communications · doi:10.1038/s41467-020-20230-z · Cited by 89
Base and Prime Editing Technologies for Blood Disorders
Antoniou, P., Miccio, A., & Brusson, M. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.618406 · Cited by 94
Volke, D. C., Martino, R. A., Kozaeva, E., Smania, A. M., & Nikel, P. I. (2022) · Nature Communications · doi:10.1038/s41467-022-30780-z · Cited by 89
Therapeutic adenine base editing of human hematopoietic stem cells
Liao, J., Chen, S., Hsiao, S., Jiang, Y., Yang, Y., Zhang, Y., Wang, X., Lai, Y., Bauer, D. E., & Wu, Y. (2023) · Nature Communications · doi:10.1038/s41467-022-35508-7 · Cited by 89
Advanced domestication: harnessing the precision of gene editing in crop breeding
Lyzenga, W. J., Pozniak, C. J., & Kagale, S. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13576 · Cited by 85
In situ readout of DNA barcodes and single base edits facilitated by in vitro transcription
Askary, A., Sánchez-Guardado, L. Ó., Linton, J. M., Chadly, D. M., Budde, M. W., Cai, L., Lois, C., & Elowitz, M. B. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0299-4 · Cited by 86
CRISPR–Cas9, CRISPRi and CRISPR-BEST-mediated genetic manipulation in streptomycetes
Tong, Y., Whitford, C. M., Blin, K., Jørgensen, T. S., Weber, T., & Lee, S. Y. (2020) · Nature Protocols · doi:10.1038/s41596-020-0339-z · Cited by 85
Yang, L., Zhang, X., Wang, L., Yin, S., Zhu, B., Xie, L., Duan, Q., Hu, H., Zheng, R., Yu, W., et al. (2018) · Protein & Cell · doi:10.1007/s13238-018-0568-x · Cited by 85
Programmable deaminase-free base editors for G-to-Y conversion by engineered glycosylase
Tong, H., Liu, N., Wei, Y., Zhou, Y., Li, Y., Wu, D., Jin, M., Cui, S., Li, H., Li, G., et al. (2023) · National Science Review · doi:10.1093/nsr/nwad143 · Cited by 87
Horie, T., & Ono, K. (2023) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvad103 · Cited by 89
Raj, B., Gagnon, J. A., & Schier, A. F. (2018) · Nature Protocols · doi:10.1038/s41596-018-0058-x · Cited by 87
Cas9 off-target binding to the promoter of bacterial genes leads to silencing and toxicity
Rostain, W., Grebert, T., Vyhovskyi, D., Pizarro, P. T., Tshinsele-Van Bellingen, G., Cui, L., & Bikard, D. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad170 · Cited by 85
Improving CRISPR-Cas9 Genome Editing Efficiency by Fusion with Chromatin-Modulating Peptides
Ding, X. L., Seebeck, T., Feng, Y., Jiang, Y., Davis, G. D., & Chen, F. (2019) · The CRISPR Journal · doi:10.1089/crispr.2018.0036 · Cited by 87
Genetic Engineering and Editing of Plants: An Analysis of New and Persisting Questions
Mackelprang, R., & Lemaux, P. G. (2020) · Annual Review of Plant Biology · doi:10.1146/annurev-arplant-081519-035916 · Cited by 86
Engineering Gene Therapy: Advances and Barriers
Shahryari, A., Burtscher, I., Nazari, Z., & Lickert, H. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100040 · Cited by 87
Genome Editing for Sustainable Crop Improvement and Mitigation of Biotic and Abiotic Stresses
Hamdan, M. F., Karlson, C. K. S., Teoh, E. Y., Lau, S.-E., & Tan, B. C. (2022) · Plants · doi:10.3390/plants11192625 · Cited by 91
Application and future perspective of CRISPR/Cas9 genome editing in fruit crops
Zhou, J., Li, D., Wang, G., Wang, F., Kunjal, M., Joldersma, D., & Liu, Z. (2019) · Journal of Integrative Plant Biology · doi:10.1111/jipb.12793 · Cited by 86
Accurate analysis of genuine CRISPR editing events with ampliCan
Labun, K., Guo, X., Chavez, A., Church, G., Gagnon, J. A., & Valen, E. (2019) · Genome Research · doi:10.1101/gr.244293.118 · Cited by 84
Mapping human cell phenotypes to genotypes with single-cell genomics
Camp, J. G., Platt, R. J., & Treutlein, B. (2019) · Science · doi:10.1126/science.aax6648 · Cited by 85
Challenges and Perspectives in Homology-Directed Gene Targeting in Monocot Plants
Vu, T. V., Sung, Y. W., Kim, J., Tran, M. T., Tran, M. T., & Kim, J. (2019) · Rice · doi:10.1186/s12284-019-0355-1 · Cited by 83
Base editing with high efficiency in allotetraploid oilseed rape by A3A‐PBE system
Cheng, H., Hao, M., Ding, B., Mei, D., Wang, W., Wang, H., Zhou, R., Liu, J., Li, C., & Hu, Q. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13444 · Cited by 84
Cancer-cell-secreted miR-122 suppresses O-GlcNAcylation to promote skeletal muscle proteolysis
Yan, W., Cao, M., Ruan, X., Jiang, L., Lee, S. Y., Lemanek, A., Ghassemian, M., Pizzo, D. P., Wan, Y., Qiao, Y., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00893-0 · Cited by 84
A detailed landscape of CRISPR-Cas-mediated plant disease and pest management
Karmakar, S., Das, P., Panda, D., Xie, K., Baig, M. J., & Molla, K. A. (2022) · Plant Science · doi:10.1016/j.plantsci.2022.111376 · Cited by 83
CRISPR/Cas9 Technology and Its Utility for Crop Improvement
Liu, H., Chen, W., Li, Y., Sun, L., Chai, Y., Chen, H., Nie, H., & Huang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810442 · Cited by 85
Hearing of Otof-deficient mice restored by trans-splicing of N- and C-terminal otoferlin
Tang, H., Wang, H., Wang, S., Hu, S. W., Lv, J., Xun, M., Gao, K., Wang, F., Chen, Y., Wang, D., et al. (2022) · Human Genetics · doi:10.1007/s00439-022-02504-2 · Cited by 86
CRISPR-Cas: A robust technology for enhancing consumer-preferred commercial traits in crops
Verma, V., Kumar, A., Partap, M., Thakur, M., & Bhargava, B. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1122940 · Cited by 84
Potent and uniform fetal hemoglobin induction via base editing
Mayuranathan, T., Newby, G. A., Feng, R., Yao, Y., Mayberry, K. D., Lazzarotto, C. R., Li, Y., Levine, R. M., Nimmagadda, N., Dempsey, E., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01434-7 · Cited by 86
Self-citationClick editing enables programmable genome writing using DNA polymerases and HUH endonucleases
da Silva, J. F., Tou, C. J., King, E. M., Eller, M. L., Rufino‐Ramos, D., Ma, L., Cromwell, C. R., Metović, J., Benning, F. M. C., Chao, L. H., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02324-x · Cited by 86
Lopes, R., & Prasad, M. K. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1339189 · Cited by 82
Targeting fidelity of adenine and cytosine base editors in mouse embryos
Lee, H., Willi, M., Miller, S. M., Kim, S., Liu, C., Liu, D. R., & Hennighausen, L. G. (2018) · Nature Communications · doi:10.1038/s41467-018-07322-7 · Cited by 82
Self-citationRecent Advances in CRISPR-Cas Technologies for Synthetic Biology
Jeong, S. H., Lee, H. J., & Lee, S. J. (2023) · The Journal of Microbiology · doi:10.1007/s12275-022-00005-5 · Cited by 88
Snipping around for food: economic, ethical and policy implications of CRISPR/Cas genome editing
Bartkowski, B., Theesfeld, I., Pirscher, F., & Timaeus, J. (2018) · Geoforum · doi:10.1016/j.geoforum.2018.07.017 · Cited by 81
Metadata
- Authors
- Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Liu, David R.
- ORCID
- Venue
- Nature
- Published
- 2017-11-01
- Volume
- 551
- Issue
- 7681
- Pages
- 464-471
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5726555
- OpenAlex
- W2766599608
- Cited by
- 4,184
- References
- 46
- Citations by year
- 2026: 460 · 2025: 501 · 2024: 521 · 2023: 599 · 2022: 557 · 2021: 489 · 2020: 474 · 2019: 332 · 2018: 237 · 2017: 8
- FWCI
- 117.56
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-05-02)
- Open access
- green
- europepmc.org
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Human Genome Research Institute (RM1HG009490)
- National Institute of General Medical Sciences (T32GM008313, F32GM106621, R35GM118062, F32GM112366)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- adenine base editors, base editing, cytosine deamination, CRISPR/Cas9, directed evolution, protein engineering, transition mutations, point mutations, single nucleotide polymorphisms
- MeSH terms
- Gene Editing, Adenosine Deaminase, DNA, Humans, Models, Molecular, Genome, Human, Base Pairing, Polymorphism, Single Nucleotide, Cell Line, Tumor, DNA Cleavage, HEK293 Cells, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
